First prevention drug for high-risk groups approved in EU
The London-based agency said that PrEP was recommended by the World Health Organisation (WHO).
Diabetes cases reach 422 million as poorer countries see steep rises
Recommended articles
The European Medicines Agency (EMA) approved the use of the drug Truvada for pre-exposure prophylaxis, or PrEP, in combination with safer sex practices.
``The drug will help people who do not have HIV but who are at high risk of infection with HIV to lower their chances of becoming infected when they are exposed to the virus.
``The oral drug should be used in combination with condoms as part of an HIV prevention strategy.
ADVERTISEMENT
``Truvada was previously approved for use in the EU as part of drug cocktails designed to treat people infected with HIV,’’ the WHO said.
The WHO estimates that some 36.7 million people worldwide were living with HIV at the end of 2015.
JOIN OUR PULSE COMMUNITY!
ADVERTISEMENT
Eyewitness? Submit your stories now via social or:
Email: eyewitness@pulse.ng
Recommended articles
How we reduced road traffic crashes by 42% – FRSC boss
Motorists express worry as long fuel queues resurface in FCT
Reno's $10,000 Challenge: I didn't build any school in Anambra, Obi opens up
Bullied student threatens Abuja school with lawsuit if abusers are not punished
EFCC withdraws appeal against Yahaya Bello
Gov Zulum wants Army to establish military base in Sambisa forest
2 Wike loyalists exit Fubara's cabinet as Governor reshuffles
Ganduje believes APC is the answer to Nigeria’s problems
Spate of deaths strikes Nigerian movie industry, Nigerians calls for action
ADVERTISEMENT
![Aliko Dangote and Tinubu [NAN]](data:image/svg+xml;charset=utf8,%3Csvg%20xmlns%3D'http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg'%20width%3D'300'%20height%3D'172'%20data-ring-placeholder%3D'1'%3E%3C%2Fsvg%3E "Aliko Dangote and Tinubu [NAN]")